The Only FDA-Approved
Treatment OF ITS KIND For
Children With EoE
If your child is having trouble with food, it's time to learn how
DUPIXENT may be able to help.
EoE in Children: Results
with Dupixent
DUPIXENT REDUCED
Inflammation in the
esophagus
CAREGIVERS OBSERVED THAT CHILDREN EXPERIENCED
FEWER DAYS WITH EoE
SIGNS
AND SYMPTOMS
AS EARLY AS 4 MONTHS AND AT 1 YEAR*
VISIBLE IMPROVEMENTS
IN THE ESOPHAGUS
WERE SEEN IN CHILDREN
DUPIXENT was studied in 61 patients ages 1 to 11 years old (≥33 lbs) with EoE in a two-part study.
*As measured by the Pediatric EoE Sign/Symptom Questionnaire-Caregiver
(PESQ-C).
The most common side effects
with EoE include:
- Injection site reactions
- Upper respiratory tract infections
- Cold sores in your mouth or on your lips
- Joint pain (arthralgia)
View the possible side effects of DUPIXENT in patients with eosinophilic esophagitis.
Results in Patients
12+ Years
DUPIXENT was also proven to reduce difficulty swallowing and reduce
inflammation in the esophagus in patients aged 12+ years.
(Ages 12+ YEARS)
Have a productive
Conversation
With
Your Doctor
Our goal is for you or your loved one to get the most out of your visit to the doctor. Fill out our personalized discussion guide to help yourself have a productive conversation during your next visit.
Find an EoE Specialist
Use the Healthgrades™ tool to easily find nearby
specialists with experience in treating patients suffering
from eosinophilic esophagitis (EoE).
Sanofi US and Regeneron do not endorse or recommend any particular physician, and search results do not include a comprehensive list of doctors in your area.
Treating Children With
DUPIXENT
DUPIXENT is a biologic medicine given under the skin (subcutaneous injection). The
recommended dose for your child can depend on age and weight.
GET EMAIL UPDATES
Sign up to get more information to help you and your child, including helpful tools and
resources, in your inbox with DUPIXENT MyWay® email updates.